Is Bio-Works Technologies AB halal to invest in?

According to Musaffa's Shariah screening methodology, Bio-Works Technologies AB (BIOWKS.ST) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Bio-Works Technologies AB a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bio-Works Technologies AB using these criteria to determine its compliance status.

Can Muslims buy shares of Bio-Works Technologies AB?

Muslim investors may consider investing in Bio-Works Technologies AB if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Bio-Works Technologies AB classified as NOT COVERED?

Musaffa determines the Shariah status of Bio-Works Technologies AB by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Bio-Works Technologies AB updated?

The Shariah compliance status of Bio-Works Technologies AB may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Bio-Works Technologies AB become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Bio-Works Technologies AB?

You can check the latest Shariah compliance status of Bio-Works Technologies AB on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Bio-Works Technologies AB BIOWKS.ST

€2.10 €0.10 (4.55%) 1D

Last Updated: Jul 17, 12:00 AM·XFRA

Bio-Works Technologies AB. Stock Analysis BIOWKS.ST

Germany Health Care Nano Cap

Bio-Works Technologies AB engages in the research and development, manufacturing, and supply of agarose-based resins. The company is headquartered in Uppsala, Uppsala and currently employs 33 full-time employees. The company went IPO on 2017-12-14. The firm designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The firm uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.

Key Statistics of Bio-Works Technologies AB (BIOWKS.ST)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€2.10€2.26

Today's Open

€2.20

Volume

11.38K

P/E Ratio (TTM)

Market Cap

6.22M

Avg. Volume

Dividend Yield

Financial Metrics & Statements of Bio-Works Technologies AB (BIOWKS.ST)

FAQ's for Bio-Works Technologies AB (BIOWKS.ST)

According to Musaffa’s Shariah screening methodology, Bio-Works Technologies AB (BIOWKS.ST) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.